The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Expression of mouse (top row) or rat (bottom row) MCP-1 by stimulated peritoneal cells. Mouse: Thioglycolate-elicited peritoneal macrophages from 6 month old BALB/c mice were stimulated with LPS (1 µg/ml; Sigma) for 5 hours in culture in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). Fc receptors were blocked using 0.5 µg of Fc Block™ (Cat. No. 553142). Cells were stained with 0.06 µg of FITC-rat anti-mouse Mac-1 antibody, fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443) by using Pharmingen's staining protocol. To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant mouse MCP-1 (0.25 µg, Cat. No. 554590; middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled 2H5 antibody (8 µg, Cat. No. 554711; right panel) prior to staining with the PE-2H5 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabeled antibody blocking (right panel) specificity controls. Rat: Peritoneal cells from Lewis rats were harvested and plated in complete RPMI for one week. Cells were stimulated with LPS (1 µg/ml final concentration; Sigma) overnight in the presence of GolgiPlug™ (1 µg/ml; Cat. No. 555029), harvested and blocked for nonspecific staining with purified rat IgG. Cells were fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443). To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant rat MCP-1 (0.25 µg, Cat. No. 555110; middle panel), and by preincubation of the fixed/ permeabilized cells with the unlabeled antibody blocking (right panel) specificity controls.
Expression of mouse (top row) or rat (bottom row) MCP-1 by stimulated peritoneal cells. Mouse: Thioglycolate-elicited peritoneal macrophages from 6 month old BALB/c mice were stimulated with LPS (1 µg/ml; Sigma) for 5 hours in culture in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). Fc receptors were blocked using 0.5 µg of Fc Block™ (Cat. No. 553142). Cells were stained with 0.06 µg of FITC-rat anti-mouse Mac-1 antibody, fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443) by using Pharmingen's staining protocol. To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant mouse MCP-1 (0.25 µg, Cat. No. 554590; middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled 2H5 antibody (8 µg, Cat. No. 554711; right panel) prior to staining with the PE-2H5 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabeled antibody blocking (right panel) specificity controls. Rat: Peritoneal cells from Lewis rats were harvested and plated in complete RPMI for one week. Cells were stimulated with LPS (1 µg/ml final concentration; Sigma) overnight in the presence of GolgiPlug™ (1 µg/ml; Cat. No. 555029), harvested and blocked for nonspecific staining with purified rat IgG. Cells were fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443). To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant rat MCP-1 (0.25 µg, Cat. No. 555110; middle panel), and by preincubation of the fixed/ permeabilized cells with the unlabeled antibody blocking (right panel) specificity controls.
Expression of mouse (top row) or rat (bottom row) MCP-1 by stimulated peritoneal cells. Mouse: Thioglycolate-elicited peritoneal macrophages from 6 month old BALB/c mice were stimulated with LPS (1 µg/ml; Sigma) for 5 hours in culture in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). Fc receptors were blocked using 0.5 µg of Fc Block™ (Cat. No. 553142). Cells were stained with 0.06 µg of FITC-rat anti-mouse Mac-1 antibody, fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443) by using Pharmingen's staining protocol. To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant mouse MCP-1 (0.25 µg, Cat. No. 554590; middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled 2H5 antibody (8 µg, Cat. No. 554711; right panel) prior to staining with the PE-2H5 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabeled antibody blocking (right panel) specificity controls. Rat: Peritoneal cells from Lewis rats were harvested and plated in complete RPMI for one week. Cells were stimulated with LPS (1 µg/ml final concentration; Sigma) overnight in the presence of GolgiPlug™ (1 µg/ml; Cat. No. 555029), harvested and blocked for nonspecific staining with purified rat IgG. Cells were fixed, permeabilized, and then stained with 0.25 µg of PE-hamster anti-mouse MCP-1 antibody (PE-2H5; Cat. No. 554443). To demonstrate specificity of staining, the binding of PE-2H5 was blocked by the preincubation of the conjugated antibody with recombinant rat MCP-1 (0.25 µg, Cat. No. 555110; middle panel), and by preincubation of the fixed/ permeabilized cells with the unlabeled antibody blocking (right panel) specificity controls.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunofluorescent Staining: The 2H5 antibody is useful for immunofluorescent staining and flow cytometric analysis to identify and enumerate MCP-1 producing cells within mixed cell populations. For optimal immunofluorescent staining for flow cytometric analysis, the anti-cytokine antibody should be titrated (≤ 0.5 µg mAb/million cells). For specific methodology, please visit the protocols sections, or the chapter on intracellular staining in the Immune Function Handbook, both of which are posted on our website, www.bdbiosciences.com.
A useful control for demonstrating specificity of staining is either of the following: 1) preblock the conjugated 2H5 antibody with a ligand (e.g., recombinant mouse MCP-1; Cat No. 554590 for mouse or recombinant rat MCP-1; Cat. No. 555110 for rat) prior to staining, or 2) pre-block the fixed/permeabilized cells with unlabeled 2H5 antibody (Cat. No. 554441) prior to staining. The staining technique and blocking controls are described in detail by C. Prussin and D. Metcalfe. A suitable hamster IgG isotype control for assessing the level of background staining on fixed/permeabilized mouse cells is PE-G235-2356 (Cat. No. 554711); use at comparable concentrations to antibody of interest (e.g., ≤ 0.5 µg mAb/1 million cells).
ELISA: Purified 2H5 antibody (Cat. No. 554441) can be used as the capture antibody in a sandwich ELISA for measuring mouse MCP-1 levels in conjunction with the biotinylated 4E2/MCP mouse antibody (Cat. No. 554444) as the detection antibody, and recombinant mouse MCP-1 (Cat. No. 554590) as the standard.
Neutralization: The NA/LE™ 2H5 antibody is useful for neutralization of mouse MCP-1 bioactivity.
The 2H5 antibody reacts with mouse and rat monocyte chemoattractant protein (MCP-1), formerly termed JE. This antibody also recognizes human MCP-1, but shows no reactivity with the closely related mouse β chemokines, TCA3 and MIP-1β. The immunogen used to generate the 2H5 hybridoma was heparin-purified CHO-expressed mouse MCP-1. This is a neutralizing antibody.
This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.